185 related articles for article (PubMed ID: 17723212)
1. The expanding universe of regulatory T cell subsets in cancer.
Gajewski TF
Immunity; 2007 Aug; 27(2):185-7. PubMed ID: 17723212
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.
Peng G; Wang HY; Peng W; Kiniwa Y; Seo KH; Wang RF
Immunity; 2007 Aug; 27(2):334-48. PubMed ID: 17656116
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
4. The role of T lymphocytes in the immunotherapy of tumours.
Brondz BD; Balashov KE
Biomed Sci; 1991; 2(5):441-9. PubMed ID: 1840832
[TBL] [Abstract][Full Text] [Related]
5. The significance of Treg cells in defective tumor immunity.
Kosmaczewska A; Ciszak L; Potoczek S; Frydecka I
Arch Immunol Ther Exp (Warsz); 2008; 56(3):181-91. PubMed ID: 18512029
[TBL] [Abstract][Full Text] [Related]
6. T regulatory cells in cancer: recent advances and therapeutic potential.
Elkord E; Alcantar-Orozco EM; Dovedi SJ; Tran DQ; Hawkins RE; Gilham DE
Expert Opin Biol Ther; 2010 Nov; 10(11):1573-86. PubMed ID: 20955112
[TBL] [Abstract][Full Text] [Related]
7. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy.
Rei M; Pennington DJ; Silva-Santos B
Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949
[TBL] [Abstract][Full Text] [Related]
8. How regulatory CD25(+)CD4(+) T cells impinge on tumor immunobiology? On the existence of two alternative dynamical classes of tumors.
Leon K; Garcia K; Carneiro J; Lage A
J Theor Biol; 2007 Jul; 247(1):122-37. PubMed ID: 17412365
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific regulatory T cells in cancer patients.
Piersma SJ; Welters MJ; van der Burg SH
Hum Immunol; 2008; 69(4-5):241-9. PubMed ID: 18486758
[TBL] [Abstract][Full Text] [Related]
10. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
11. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
12. Gammadelta T cell receptors without a job.
Kapsenberg ML
Immunity; 2009 Aug; 31(2):181-3. PubMed ID: 19699169
[TBL] [Abstract][Full Text] [Related]
13. T cell subsets and colorectal cancer: discerning the good from the bad.
Scurr M; Gallimore A; Godkin A
Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
[TBL] [Abstract][Full Text] [Related]
14. Gammadelta T cells recognize tumor cells via CDR3delta region.
Xu C; Zhang H; Hu H; He H; Wang Z; Xu Y; Chen H; Cao W; Zhang S; Cui L; Ba D; He W
Mol Immunol; 2007 Jan; 44(4):302-10. PubMed ID: 16650897
[TBL] [Abstract][Full Text] [Related]
15. Effector/memory but not naive regulatory T cells are responsible for the loss of concomitant tumor immunity.
Lin YC; Chang LY; Huang CT; Peng HM; Dutta A; Chen TC; Yeh CT; Lin CY
J Immunol; 2009 May; 182(10):6095-104. PubMed ID: 19414761
[TBL] [Abstract][Full Text] [Related]
16. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
Wang RF
Hum Immunol; 2008 Nov; 69(11):811-4. PubMed ID: 18817828
[TBL] [Abstract][Full Text] [Related]
17. Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R; Celis E
Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
[TBL] [Abstract][Full Text] [Related]
18. gammadelta T cell selection: is anyone useless?
Bonneville M
Immunity; 2008 Jul; 29(1):3-5. PubMed ID: 18631449
[TBL] [Abstract][Full Text] [Related]
19. Tumor infiltrating regulatory T cells: tractable targets for immunotherapy.
Khan AR; Dovedi SJ; Wilkinson RW; Pritchard DI
Int Rev Immunol; 2010 Oct; 29(5):461-84. PubMed ID: 20839911
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the prognostic value of regulatory T cells in patients with cancer.
Badoual C; Hans S; Fridman WH; Brasnu D; Erdman S; Tartour E
J Clin Oncol; 2009 Jul; 27(19):e5-6; author reply e7. PubMed ID: 19470910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
